Cargando…

MFI2 upregulation promotes malignant progression through EGF/FAK signaling in oral cavity squamous cell carcinoma

Oral squamous cell carcinoma (OSCC) is the predominant histological type of the head and neck squamous cell carcinoma (HNSCC). By comparing the differentially expressed genes (DEGs) in OSCC-TCGA patients with copy number variations (CNVs) that we identify in OSCC-OncoScan dataset, we herein identifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yen, Wei-Chen, Chang, Kai-Ping, Chen, Cheng-Yi, Huang, Yenlin, Chen, Ting-Wen, Cheng, Hsing-Wen, Yi, Jui-Shan, Cheng, Chun-Chia, Wu, Chih-Ching, Wang, Chun-I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259005/
https://www.ncbi.nlm.nih.gov/pubmed/37309001
http://dx.doi.org/10.1186/s12935-023-02956-0
_version_ 1785057575390150656
author Yen, Wei-Chen
Chang, Kai-Ping
Chen, Cheng-Yi
Huang, Yenlin
Chen, Ting-Wen
Cheng, Hsing-Wen
Yi, Jui-Shan
Cheng, Chun-Chia
Wu, Chih-Ching
Wang, Chun-I
author_facet Yen, Wei-Chen
Chang, Kai-Ping
Chen, Cheng-Yi
Huang, Yenlin
Chen, Ting-Wen
Cheng, Hsing-Wen
Yi, Jui-Shan
Cheng, Chun-Chia
Wu, Chih-Ching
Wang, Chun-I
author_sort Yen, Wei-Chen
collection PubMed
description Oral squamous cell carcinoma (OSCC) is the predominant histological type of the head and neck squamous cell carcinoma (HNSCC). By comparing the differentially expressed genes (DEGs) in OSCC-TCGA patients with copy number variations (CNVs) that we identify in OSCC-OncoScan dataset, we herein identified 37 dysregulated candidate genes. Among these potential candidate genes, 26 have been previously reported as dysregulated proteins or genes in HNSCC. Among 11 novel candidates, the overall survival analysis revealed that melanotransferrin (MFI2) is the most significant prognostic molecular in OSCC-TCGA patients. Another independent Taiwanese cohort confirmed that higher MFI2 transcript levels were significantly associated with poor prognosis. Mechanistically, we found that knockdown of MFI2 reduced cell viability, migration and invasion via modulating EGF/FAK signaling in OSCC cells. Collectively, our results support a mechanistic understanding of a novel role for MFI2 in promoting cell invasiveness in OSCC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-023-02956-0.
format Online
Article
Text
id pubmed-10259005
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102590052023-06-13 MFI2 upregulation promotes malignant progression through EGF/FAK signaling in oral cavity squamous cell carcinoma Yen, Wei-Chen Chang, Kai-Ping Chen, Cheng-Yi Huang, Yenlin Chen, Ting-Wen Cheng, Hsing-Wen Yi, Jui-Shan Cheng, Chun-Chia Wu, Chih-Ching Wang, Chun-I Cancer Cell Int Research Oral squamous cell carcinoma (OSCC) is the predominant histological type of the head and neck squamous cell carcinoma (HNSCC). By comparing the differentially expressed genes (DEGs) in OSCC-TCGA patients with copy number variations (CNVs) that we identify in OSCC-OncoScan dataset, we herein identified 37 dysregulated candidate genes. Among these potential candidate genes, 26 have been previously reported as dysregulated proteins or genes in HNSCC. Among 11 novel candidates, the overall survival analysis revealed that melanotransferrin (MFI2) is the most significant prognostic molecular in OSCC-TCGA patients. Another independent Taiwanese cohort confirmed that higher MFI2 transcript levels were significantly associated with poor prognosis. Mechanistically, we found that knockdown of MFI2 reduced cell viability, migration and invasion via modulating EGF/FAK signaling in OSCC cells. Collectively, our results support a mechanistic understanding of a novel role for MFI2 in promoting cell invasiveness in OSCC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-023-02956-0. BioMed Central 2023-06-12 /pmc/articles/PMC10259005/ /pubmed/37309001 http://dx.doi.org/10.1186/s12935-023-02956-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Yen, Wei-Chen
Chang, Kai-Ping
Chen, Cheng-Yi
Huang, Yenlin
Chen, Ting-Wen
Cheng, Hsing-Wen
Yi, Jui-Shan
Cheng, Chun-Chia
Wu, Chih-Ching
Wang, Chun-I
MFI2 upregulation promotes malignant progression through EGF/FAK signaling in oral cavity squamous cell carcinoma
title MFI2 upregulation promotes malignant progression through EGF/FAK signaling in oral cavity squamous cell carcinoma
title_full MFI2 upregulation promotes malignant progression through EGF/FAK signaling in oral cavity squamous cell carcinoma
title_fullStr MFI2 upregulation promotes malignant progression through EGF/FAK signaling in oral cavity squamous cell carcinoma
title_full_unstemmed MFI2 upregulation promotes malignant progression through EGF/FAK signaling in oral cavity squamous cell carcinoma
title_short MFI2 upregulation promotes malignant progression through EGF/FAK signaling in oral cavity squamous cell carcinoma
title_sort mfi2 upregulation promotes malignant progression through egf/fak signaling in oral cavity squamous cell carcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259005/
https://www.ncbi.nlm.nih.gov/pubmed/37309001
http://dx.doi.org/10.1186/s12935-023-02956-0
work_keys_str_mv AT yenweichen mfi2upregulationpromotesmalignantprogressionthroughegffaksignalinginoralcavitysquamouscellcarcinoma
AT changkaiping mfi2upregulationpromotesmalignantprogressionthroughegffaksignalinginoralcavitysquamouscellcarcinoma
AT chenchengyi mfi2upregulationpromotesmalignantprogressionthroughegffaksignalinginoralcavitysquamouscellcarcinoma
AT huangyenlin mfi2upregulationpromotesmalignantprogressionthroughegffaksignalinginoralcavitysquamouscellcarcinoma
AT chentingwen mfi2upregulationpromotesmalignantprogressionthroughegffaksignalinginoralcavitysquamouscellcarcinoma
AT chenghsingwen mfi2upregulationpromotesmalignantprogressionthroughegffaksignalinginoralcavitysquamouscellcarcinoma
AT yijuishan mfi2upregulationpromotesmalignantprogressionthroughegffaksignalinginoralcavitysquamouscellcarcinoma
AT chengchunchia mfi2upregulationpromotesmalignantprogressionthroughegffaksignalinginoralcavitysquamouscellcarcinoma
AT wuchihching mfi2upregulationpromotesmalignantprogressionthroughegffaksignalinginoralcavitysquamouscellcarcinoma
AT wangchuni mfi2upregulationpromotesmalignantprogressionthroughegffaksignalinginoralcavitysquamouscellcarcinoma